Successful treatment of 2 patients with brain metastases from non-small cell lung cancer with epidermal growth factor receptor mutation receiving dacomitinib: A case report

RATIONALE: Approximately 20% of patients with non-small cell lung cancer (NSCLC) are diagnosed with brain metastasis, which is related to poor survival outcomes. The ability of tyrosine kinase inhibitor drugs to penetrate the blood–brain barrier makes them a potential option for intracranial metasta...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Songchen, Cong, Xiaofeng, Liu, Ziling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322497/
https://www.ncbi.nlm.nih.gov/pubmed/34397694
http://dx.doi.org/10.1097/MD.0000000000026680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322497/
https://www.ncbi.nlm.nih.gov/pubmed/34397694
http://dx.doi.org/10.1097/MD.0000000000026680

Ejemplares similares